Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (261-270 of 437) with videos related to

Pageof 44
Sort By:
Bone Marrow Transplantation|January 26, 2023
Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectivesHilda Mekelenkamp, Martine de Vries, Benny Markovitch, et al.
Frontiers in Immunology|February 16, 2017
Treatment of Infantile Inflammatory Bowel Disease and Autoimmunity by Allogeneic Stem Cell Transplantation in LPS-Responsive Beige-Like Anchor DeficiencyShahrzad Bakhtiar, Laura Gámez-Díaz, Andrea Jarisch, et al.
Bone Marrow Transplantation|August 6, 2003
T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosisM H Albert, F Schuster, C Peters, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.
Journal of Medicinal Chemistry|December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonistS K Davidsen, J B Summers, D H Albert, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
European Cytokine Network|July 15, 2006
Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory responseSilvia Stojanov, Florian Hoffmann, Anja Kéry, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonistD H Albert, R G Conway, T J Magoc, et al.
Bone Marrow Transplantation|July 6, 2021
EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunityA C Lankester, M H Albert, C Booth, et al.
Ecology and Evolution|January 2, 2019
Differences in the fungal communities nursed by two genetic groups of the alpine cushion plant, <i>Silene acaulis</i>Julien Roy, Jean-Marc Bonneville, Patrick Saccone, et al.
Pageof 44

Showing results (261-270 of 437) with videos related to

Sort By:
Pageof 44
Bone Marrow Transplantation|January 26, 2023
Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectivesHilda Mekelenkamp, Martine de Vries, Benny Markovitch, et al.
Frontiers in Immunology|February 16, 2017
Treatment of Infantile Inflammatory Bowel Disease and Autoimmunity by Allogeneic Stem Cell Transplantation in LPS-Responsive Beige-Like Anchor DeficiencyShahrzad Bakhtiar, Laura Gámez-Díaz, Andrea Jarisch, et al.
Bone Marrow Transplantation|August 6, 2003
T-cell-depleted peripheral blood stem cell transplantation for alpha-mannosidosisM H Albert, F Schuster, C Peters, et al.
Journal of Cardiovascular Pharmacology|February 4, 2009
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented ratsPatricia N Banfor, Pamela A Franklin, Jason A Segreti, et al.
Journal of Medicinal Chemistry|December 23, 1994
N-(acyloxyalkyl)pyridinium salts as soluble prodrugs of a potent platelet activating factor antagonistS K Davidsen, J B Summers, D H Albert, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2012
FDG-PET as a pharmacodynamic biomarker for early assessment of treatment response to linifanib (ABT-869) in a non-small cell lung cancer xenograft modelSarah R Mudd, Martin J Voorbach, David R Reuter, et al.
European Cytokine Network|July 15, 2006
Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory responseSilvia Stojanov, Florian Hoffmann, Anja Kéry, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1996
Properties of ABT-299, a prodrug of A-85783, a highly potent platelet activating factor receptor antagonistD H Albert, R G Conway, T J Magoc, et al.
Bone Marrow Transplantation|July 6, 2021
EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunityA C Lankester, M H Albert, C Booth, et al.
Ecology and Evolution|January 2, 2019
Differences in the fungal communities nursed by two genetic groups of the alpine cushion plant, <i>Silene acaulis</i>Julien Roy, Jean-Marc Bonneville, Patrick Saccone, et al.
Pageof 44